Brusartan 100mg

Страна: Армения

Език: английски

Източник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активна съставка:

losartan (losartan potassium)

Предлага се от:

Brupharmexport sprl

INN (Международно Name):

losartan (losartan potassium)

дозиране:

100mg

Лекарствена форма:

tablets film-coated

Вид предписание :

Prescription

Данни за продукта

1
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT
BRUSARTAN 50MG
BRUSARTAN 100MG
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each BRUSARTAN 50 mg film-coated tablet contains 50 mg losartan
potassium.
Each BRUSARTAN 100 mg film-coated tablet contains 100 mg losartan
potassium.
For full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Film-coated tablet (tablet).
BRUSARTAN 50 mg: film-coated, white to off-white, oval shaped scored
tablets.
Tablets can be divided into equal halves.
BRUSARTAN 100 mg: film-coated, white to off-white, oval shaped scored
tablets.
Tablets can be divided into equal halves.
4. CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Treatment of essential hypertension in adults and in children and
adolescents 6 – 18 years of age.
Treatment of renal disease in adult patients with hypertension and
type 2 diabetes mellitus with proteinuria
≥0.5 g/day as part of an anti-hypertensive treatment.
Treatment of chronic heart failure (in patients ≥60 years), when
treatment with Angiotensin-Converting
Enzyme
(ACE)
inhibitors
is
not
considered
suitable
due
to
incompatibility,
especially
cough,
or
contraindication. In patients with heart failure who have been
stabilized with an ACE inhibitor, a switch to
losartan is not recommended. The patients should have a left
ventricular ejection fraction ≤40% and should
be stabilized under the treatment of the chronic heart failure.
Reduction in the risk of stroke in hypertensive patients with left
ventricular hypertrophy documented by
ECG (see 5.1: LIFE study, Race).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
BRUSARTAN tablets should be swallowed with a glass of water.
BRUSARTAN may be administered with or without food.
2
HYPERTENSION
The usual starting and maintenance dose is 50 mg once daily for most
patients. The maximal anti-
hypertensive effect is attained 3 - 6 weeks after initiation of
therapy. Some patients may receive an additional
benefit by increasing the dose to 100 mg once daily (in the morning).
Losartan
may
be
adminis